Navigation Links
Annai Systems And ThoughtWorks Develop Evidence Engine For The Clearity Foundation To Individualize Options For Treatment Of Ovarian Cancer
Date:11/15/2012

SAN DIEGO and LOS GATOS, Calif., Nov. 15, 2012 /PRNewswire/ -- The Clearity Foundation (Clearity) and Annai Systems today announced the implementation of a software-driven system (the MedTrust Evidence Engine-E2) that supports Clearity's mission to individualize treatment options for ovarian cancer patients.  As a result, Clearity is now more efficiently integrating and interpreting data from many sources, including its Diane Barton Database of more than 250 tumor profiles, enabling it to respond to more women who need help in personalizing treatment for their recurrent ovarian cancer.  The MedTrust E2 system was developed by Annai in close collaboration with ThoughtWorks, a global company wholly devoted to the art and science of software development.

Ovarian cancer survival has not improved significantly in decades, largely because of a trial-and-error approach to treating cancer recurrence.  It is now known that ovarian cancer is a heterogeneous disease, and tumors have significantly different characteristics from one patient to the next.  While DNA sequencing, gene expression analysis and other technologies have increasingly made it possible to develop molecular profiles of individual tumors, integrating and interpreting this data and extracting the implications of these profiles for personalized patient care are challenging.  The Clearity Foundation has developed a pro bono service to help patients and their physicians overcome these challenges and to enable more informed decisions about treatment options.  Annai's E2 has automated key steps in the process used by Clearity to deliver this service.  "Clearity can now more efficiently create tumor profiles for our patients and identify personalized treatment options," said Dr. Deborah Zajchowski, Clearity's Scientific Director.   

Hosted by Annai, the MedTrust E2 software system is capable of drawing upon the scientific literature, a wide variety o
'/>"/>

SOURCE The Clearity Foundation; Annai Systems
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Varian Medical Systems to Exhibit Flat Panel Detectors, X-Ray Tubes and Imaging Software Optimized for Digital Radiography at MEDICA
2. Frost & Sullivan: Global Increase in Adoption of Real-Time Location Systems Depends on Technological Innovations
3. Ingenuity Systems and Laboratory Corporation of America Announce Molecular Diagnostic Collaboration
4. Varian Medical Systems Management to Present at Jefferies 2012 Global Healthcare Conference
5. Varian Medical Systems Management to Present at Lazard Capital Markets 9th Annual Healthcare Conference
6. Varian Medical Systems Selected by Leading Russian Development Foundations to Take Part in High-Profile Supplier Event
7. Aushon BioSystems ernennt Bill Williams zum neuen Vice President of Sales
8. Aushon BioSystems Appoints Bill Williams Vice President of Sales
9. American Board of Radiology Foundation receives grant from Varian Medical Systems for national brachytherapy registry
10. Varian Medical Systems to Proceed with Year End Review and Webcast for Investors at ASTRO Meeting in Boston
11. Oncology Systems Limited UK Renews Research and Collaboration Agreement with University Hospital Birmingham NHS Foundation Trust (UHB) - Radiotherapy Department
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... 7 de julio de 2015 Sequent ... privada centrada en el desarrollo de dispositivos innovadores ... anunciado hoy que R. Michael Kleine ... Kleine cuenta con más de 25 ... dispositivos médicos y la sanidad. Ha gestionado con ...
(Date:7/7/2015)... , July 7, 2015 According to ... Method (Manual, Automated), Product (Consumables, Instrument), Application (Aerobic, Anaerobic, Yeast/ ... Research Institute) - Forecast to 2019", published by MarketsandMarkets, The ... Million by 2019 from $2,750.2 Million in 2014 at a ... 1 78 ma rket data ...
(Date:7/7/2015)... Accelovance, Inc. (Accelovance), a global contract ... General Medicine announced the completion of enrollment and ... Therapeutics, Inc. for the Phase 3 trial of ... SUSTOL® (granisetron injection, extended release) as part of ... receptor antagonist fosaprepitant and IV corticosteroid dexamethasone ...
Breaking Medicine Technology:Sequent Medical nombra a Mike Kleine a su junta directiva 2Sequent Medical nombra a Mike Kleine a su junta directiva 3Blood Culture Tests Market Worth $3,893.5 Million by 2019 2Blood Culture Tests Market Worth $3,893.5 Million by 2019 3Blood Culture Tests Market Worth $3,893.5 Million by 2019 4Accelovance Completes Trial Enrollment and Delivery of Clinical Data for Heron Therapeutics' Phase 3 Trial 2
... WIRE)--May 15, 2007 - Synthetic Blood,International, Inc. ... analysis of its Phase IIa study with ... line with preliminary,study results announced in December ... of increasing patients' oxygen,tension levels compared with ...
... WIRE)--May 17, 2007 - Salix,Pharmaceuticals, Ltd. (NASDAQ:SLXP) today ... the Company's products,will be presented at Digestive Disease ... Digestive Disease Week is considered the,largest and most ... Every year it attracts more than 16,000 physicians,researchers ...
Cached Medicine Technology:Positive Statistical Analysis from Synthetic Blood's Oxycyte,Traumatic Brain Injury Trial Indicates Achievement of Primary,Endpoint 2Positive Statistical Analysis from Synthetic Blood's Oxycyte,Traumatic Brain Injury Trial Indicates Achievement of Primary,Endpoint 3Salix Pharmaceuticals Previews Digestive Disease Week 2007 2Salix Pharmaceuticals Previews Digestive Disease Week 2007 3Salix Pharmaceuticals Previews Digestive Disease Week 2007 4Salix Pharmaceuticals Previews Digestive Disease Week 2007 5
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... ... Times highlights rumors about possible facial rejuvenation that have emerged about Hillary Clinton. ... U.S. Secretary of State looks more youthful than she has in some time ...
(Date:7/7/2015)... ... , ... Greatist today announced the acquisition of Blood, Sweat ... most fun activities to do with friends. , The acquisition of BSC strengthens Greatist’s ... for events, e-commerce, and brand partnerships. , “I’ve been a huge fan of Blood, ...
(Date:7/7/2015)... ... July 07, 2015 , ... Illinois cannabis cultivation centers ... to permit holders. The Medical Cannabis Alliance of Illinois’ (MCAI) board and its ... are committed to making sure patients have access to cannabis as a viable ...
(Date:7/7/2015)... ... ... the end of June Pacific Prime Renewals team in Hong Kong announced that they ... Renewals Manager, Danielle Cotton, aims to not only reduce but eventually eliminate the use of ... send anything between 300 and 600 pieces of paper per month. Not to mention A4 ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... enhance the experience for its patient community using its IDF ePHR, an electronic ... with primary immunodeficiency diseases (PI) to easily track their health information, including symptoms, ...
Breaking Medicine News(10 mins):Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 2Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 3Health News:Greatist Acquires Active Lifestyle Brand Blood, Sweat & Cheers 2Health News:Cannabis Growers and Dispensaries Form Medical Cannabis Alliance of Illinois 2Health News:Pacific Prime Hong Kong Renewals Team Starts Push to go Green 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 3
... 6 Osteotech, Inc.,(Nasdaq: OSTE ) announced today ... million from third quarter 2006 revenue of $23.4,million. Revenue ... $17.6 million for the three months ended September 30,2007 ... same segments for the,third quarter of 2006. Gross margin ...
... Thursday, November 8,2007, at 8:30 a.m. Eastern/2:30 p.m. Central ... CTIC and MTAX: CTIC),management team will host ... quarter achievements and financial results. Conference Call ... a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific Time ...
... Nov. 6 Rigel,Pharmaceuticals, Inc. (Nasdaq: RIGL ) today ... September 30, 2007. For the third quarter of 2007, ... share, compared to a net loss of $11.4 million, or,$0.46 ... shares,outstanding for the third quarters of 2007 and 2006 were ...
... - Elsevier Signs Agreement With Bayer HealthCare ... healthcare company, Bayer,HealthCare AG, headquartered in Leverkusen, Germany, ... in electronic format for,the first time, EMBASE Classic ... Excerpta Medica Abstract Journals published between 1947 and,1973. ...
... NASDAQ: CRME TSX: COM, VANCOUVER, Nov. 5 /PRNewswire-FirstCall/ ... announced that Bob Rieder, Chairman and,Chief Executive Officer, will ... Annual Healthcare Conference in New York at 1:20pm Eastern,Time ... A live webcast of Mr. Rieder,s presentation can be ...
... Nov. 5 StatSure Diagnostic,Systems, Inc. (OTC Bulletin ... Drug Administration ("FDA"), through its Center for Devices ... Clinical Laboratory,Improvements Amendments of 1988 ("CLIA") for an ... technology. The HIV 1/2 product,is marketed and distributed ...
Cached Medicine News:Health News:Osteotech Reports 2007 Third Quarter Financial Results; Core Segment Revenue Increased 28%; Gross Margin Improved to 55%; Diluted Earnings Per Share of $.09 2Health News:Osteotech Reports 2007 Third Quarter Financial Results; Core Segment Revenue Increased 28%; Gross Margin Improved to 55%; Diluted Earnings Per Share of $.09 3Health News:Osteotech Reports 2007 Third Quarter Financial Results; Core Segment Revenue Increased 28%; Gross Margin Improved to 55%; Diluted Earnings Per Share of $.09 4Health News:Osteotech Reports 2007 Third Quarter Financial Results; Core Segment Revenue Increased 28%; Gross Margin Improved to 55%; Diluted Earnings Per Share of $.09 5Health News:Rigel Announces Third Quarter 2007 Financial Results 2Health News:Rigel Announces Third Quarter 2007 Financial Results 3Health News:Rigel Announces Third Quarter 2007 Financial Results 4Health News:EMBASE Classic Makes Inroads into Pharmaceutical Industry 2Health News:EMBASE Classic Makes Inroads into Pharmaceutical Industry 3Health News:Cardiome to Present at CIBC Conference 2Health News:Cardiome to Present at CIBC Conference 3Health News:StatSure's Patented HIV 'Barrel' Technology Receives CLIA Waiver From FDA 2Health News:StatSure's Patented HIV 'Barrel' Technology Receives CLIA Waiver From FDA 3
... series slit lamp biomicroscopy ... & small pupil exams. ... capability, specifically addressing maximum ... fundus image resolution & ...
Volk indirect lenses. General diagnosis / small pupil examinations....
... contact class is particularly suitable ... which have a smaller distance ... reduction prism than the Haag-Streit ... / iridocornea. Mirror angle 59° ...
... the standard for steam Sterilization. The Tuttnauer ... healthcare and laboratory facility. Our basic manual ... needs. Time tested reliability and durability are ... M Series is also available in a ...
Medicine Products: